Sign in

CIK 0000200406

  • Large accelerated filer

JOHNSON & JOHNSON

Sign in to watch
Ticker
JNJ
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Jan 3
Incorporated
NJ
Entity type
Operating
EIN
221024240
Phone
+1 732-524-2455
Business address
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
Former names
JOHNSON & JOHNSON ET AL
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Director bought 1,250 shares at $206.15 ($257,688)
  5. 4 Open-market sale 10% owner sold 6,337 shares at $10.03 ($63,560)
  6. 4 Open-market sale 10% owner sold 2,700 shares at an average $10.05 ($27,132)
  7. 4 Open-market sale 10% owner sold 1,000 shares at $10.00 ($10,000)
  8. 4 Open-market sale 10% owner sold 52,532 shares at an average $10.21 ($536,310)
  9. 4 Open-market sale EVP, Innovative Medicine, R&D sold 21,721 shares at $192.71 ($4,185,793)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale EVP, WWC. Innovative Medicine sold 56,471 shares at $177.81 ($10,040,883)
  15. 4 Shares withheld for taxes Executive VP, General Counsel gave up 9,570 shares (to pay taxes)
  16. 4 Open-market sale CEO and Chairman of the Board sold 125,824 shares at $179.21 ($22,548,655)
  17. 4 Open-market sale Exec VP, CFO sold 16,820 shares at $176.91 ($2,975,571)
  18. 4 Open-market sale EVP, Innovative Medicine, R&D sold 19,137 shares at $163.55 ($3,129,830)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 4 of 98 · 1,944 filings